Search results

51. Studies on generation conditions and identification of reactive intermediates from model antitumor acridinone derivative…

Principal investigator: dr Agnieszka Potęga

Politechnika Gdańska, Wydział Chemiczny

Call: SONATA 4, Panel: NZ7

52. DNA double-stranded break repair proteins as a target for personalized cancer therapy based on synthetic lethality

Principal investigator: dr hab. Tomasz Śliwiński

Uniwersytet Łódzki, Wydział Biologii i Ochrony Środowiska

Call: OPUS 4, Panel: NZ7

53. The study of mechanisms that enhance the antitumor activity of 5-FU by the use of vitamin D analogs in human colon cance…

Principal investigator: dr Magdalena Milczarek

Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk

Call: PRELUDIUM 3, Panel: NZ5

54. The study of the role of mGluR8 in cancer cells - a potential target for new antitumor strategies

Principal investigator: dr Danuta Jantas

Instytut Farmakologii PAN

Call: OPUS 3, Panel: NZ3

55. Organometallic inhibitors of tubulin polymerisation. Synthesis, anticancer activities and tubulin affinities.

Principal investigator: dr hab. Damian Plażuk

Uniwersytet Łódzki, Wydział Chemii

Call: OPUS 3, Panel: ST5

56. Development of methods for the synthesis of flourinated isoselenocyanate sulforaphane analogs with expected improved ant…

Principal investigator: Tomasz Paweł Cierpiał

Centrum Badań Molekularnych i Makromolekularnych PAN

Call: PRELUDIUM 3, Panel: ST5

57. New benzo[b]furane and dicarboximide derivatives with anticancer activity- studies on the mechanism of action in human c…

Principal investigator: Karolina Królewska

Centrum Badań Molekularnych i Makromolekularnych PAN

Call: PRELUDIUM 3, Panel: NZ7

58. Conjugated linoleic acid (CLA)-induced transcriptional activation of PPAR-an investigation of molecular machanisms of pu…

Principal investigator: prof. Teresa Leszczyńska

Uniwersytet Rolniczy im. Hugona Kołłątaja w Krakowie, Wydział Technologii Żywności

Call: OPUS 2, Panel: NZ9

59. Activity evaluation of procaryotic TA modules in a dual-component model of cancer therapy

Principal investigator: Łukasz Janusz Wieteska

Uniwersytet Medyczny w Łodzi, Wydział Nauk o Zdrowiu; Zakład Biochemii Medycznej

Call: PRELUDIUM 2, Panel: NZ5

60. Synthesis, structure analysis, anticancer and antimicrobial activity of new derivatives of salinomycin

Principal investigator: dr hab. Adam Włodzimierz Huczyński

Uniwersytet im. Adama Mickiewicza w Poznaniu, Wydział Chemii

Call: SONATA 2, Panel: ST5

61. CD200R signaling in infmallation and immune cancer responses: a tricky balance

Principal investigator: dr Tomasz Piotr Rygiel

Warszawski Uniwersytet Medyczny, I Wydział Lekarski

Call: SONATA 2, Panel: NZ6

62. New drug carriers in targeted anticancer therapy

Principal investigator: prof. Artur Piotr Terzyk

Uniwersytet Mikołaja Kopernika, Wydział Chemii

Call: OPUS 1, Panel: ST5

63. Natural and synthetic isothiocyanates as a compounds with potential anticancer activity

Principal investigator: Mateusz Psurski

Politechnika Wrocławska, Wydział Chemiczny

Call: PRELUDIUM 1, Panel: NZ4

64. Stilbene and stilbazole derivatives as potential cyclooxygenase-2 (COX-2) inhibitors with probable antitumor and chemopr…

Principal investigator: Miłosz Jakub Regulski

Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Wydział Farmaceutyczny

Call: PRELUDIUM 1, Panel: NZ4

65. The new benzanilide derivates as promising anticancer agents

Principal investigator: dr hab. Marek Arkadiusz Murias

Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Wydział Farmaceutyczny

Call: OPUS 1, Panel: NZ4

66. Novel, chemometrically assisted, metabolic based research strategy in anticancer drug development on the example of benz…

Principal investigator: Mariusz Marcin Belka

Gdański Uniwersytet Medyczny, Wydział Faramcautyczny z Oddziałem Medycyny Laboratoryjnej

Call: PRELUDIUM 1, Panel: NZ1

67. Iron chelators- the novel approach to anticancer therapy

Principal investigator: Maciej Michał Serda

UNIWERSYTET ŚLĄSKI, Wydział Matematyki Fizyki i Chemii

Call: PRELUDIUM 1, Panel: NZ4

68. Targeting MMP-9 in Cancer Treatment: Computational Design and Experimental Validation of Potent, Safe Antitumor Agents

Principal investigator: dr Anna Żądło-Dobrowolska

Instytut Chemii Organicznej Polska Akademia Nauk

Call: SONATA BIS 15, Panel: ST5

69. Effect of dietary modulation of RAGE/AGE axis on prostatic neuroendocrine differentiation and the efficacy of anticancer…

Principal investigator: dr Wawrzyniec Dobrucki

Gdański Uniwersytet Medyczny

Call: OPUS 29, Panel: NZ7

70. Strategy to overcome the "ionic checkpoint" and improve the antitumor immunotherapy.

Principal investigator: dr Beata Pyrzyńska

Warszawski Uniwersytet Medyczny

Call: OPUS 29, Panel: NZ7

71. Functional nanomaterials based on drug–lipid–ligands as targeted delivery systems for anticancer agents in lung adenocar…

Principal investigator: Piotr Paweł Szyk

Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

Call: PRELUDIUM 24, Panel: NZ7

72. Development of novel 1,3-selenazol-2-one derivatives incorporated into self-emulsifying drug delivery systems as a strat…

Principal investigator: dr hab. Robert Czarnomysy

Uniwersytet Medyczny w Białymstoku

Call: OPUS 29, Panel: NZ7

73. Simulation of complex biological systems assisted by artificial intelligence: language-controlled model for cancer thera…

Principal investigator: prof. Witold Dzwinel

Akademia Górniczo-Hutnicza im. Stanisława Staszica w Krakowie

Call: OPUS 29, Panel: ST6

74. Dual cell cycle blockade and immune checkpoint inhibition as a potential strategy of sequential anticancer therapy

Principal investigator: Alicja Stanisława Słota

Uniwersytet Jagielloński

Call: PRELUDIUM 24, Panel: NZ7

75. Next-Generation Exosome Therapy: Engineering NK Cell-Derived Vesicles for Targeted Cancer Treatment

Principal investigator: dr Daria Nawrocka

Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk

Call: SONATINA 9, Panel: NZ6

76. Neutrophil Dynamics: Unveiling Anti-Tumor and Therapy Efficacy with the TUmor Neutrophil Immunotherapy on Chip (TUNIC) m…

Principal investigator: dr Martin Nurmik

Międzynarodowy Instytut Mechanizmów i Maszyn Molekularnych Polskiej Akademii Nauk

Call: SONATA 20, Panel: NZ6

77. Human exosomes as natural carriers of protein kinase CK2 inhibitors and degraders in targeted anticancer therapy.

Principal investigator: dr hab. Patrycja Joanna Wińska

Politechnika Warszawska

Call: OPUS 28 (LAP), Panel: NZ5

78. Canonical and non-canonical roles of DDK in oncogenesis: a cornerstone for the development of novel, potent anticancer t…

Principal investigator: dr Jan Marian Suski

Międzynarodowy Instytut Mechanizmów i Maszyn Molekularnych Polskiej Akademii Nauk

Call: SONATA BIS 14, Panel: NZ3

79. The two are better than one - biferrocenyl ROS generators as intelligent anticancer agents

Principal investigator: prof. Konrad Maciej Kowalski

Uniwersytet Łódzki

Call: OPUS 27, Panel: ST5

80. Potential pharmacological strategies aimed at alleviating cognitive dysfunctions accompanying oncological therapy while …

Principal investigator: dr hab. Joanna Monika Wierońska

Instytut Farmakologii PAN

Call: OPUS 26, Panel: NZ5

81. Bacterial membrane carriers targeting tumor-associated microbes for advanced cancer therapy

Principal investigator: dr Monika Kluzek

Międzynarodowy Instytut Mechanizmów i Maszyn Molekularnych Polskiej Akademii Nauk

Call: OPUS 26, Panel: NZ7

82. Design and microfluidic synthesis of hybrid nanocarriers stabilized by novel sugar surfactants as a potential anticancer…

Principal investigator: dr hab. Urszula Jolanta Bazylińska

Politechnika Wrocławska

Call: SONATA BIS 13, Panel: ST4

83. Searching for novel regulators of antitumor immune response

Principal investigator: dr hab. Magdalena Hanna Winiarska

Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

Call: MAESTRO 15, Panel: NZ6

84. Molecular mechanisms of DNA damage triggered by PIM kinases inhibition and its consequences for activation of innate imm…

Principal investigator: prof. Przemysław Juszczyński

Instytut Hematologii i Transfuzjologii

Call: OPUS 25, Panel: NZ5

85. Development of dual immuno-oligo- biosensors for monitoring and controlling of the metastatic colorectal cancer and inve…

Principal investigator: dr hab. Magdalena Stobiecka

Szkoła Główna Gospodarstwa Wiejskiego w Warszawie, Instytut Biologii

Call: OPUS 25, Panel: ST4

86. Anticancer potential of TMPyP4 porphyrin in breast cancer photodynamic therapy and evaluation of the treatment safety

Principal investigator: prof. Błażej Rubiś

Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

Call: OPUS 25, Panel: NZ7

87. Targeting Energy Metabolism for Precision Cancer Therapy: Novel Inhibitors of LDH-A and PDK1 as Potential Strategies to …

Principal investigator: Marika Anna Frańczak

Gdański Uniwersytet Medyczny, Wydział Lekarski

Call: PRELUDIUM 22, Panel: NZ7

88. Myeloid cell subpopulations as a source of effector cells for anticancer therapies using CAR chimeric receptors

Principal investigator: dr hab. Angelika Muchowicz

Warszawski Uniwersytet Medyczny, Wydział Lekarski

Call: OPUS 25, Panel: NZ6

89. Targeting undruggable proteins involved in tumorigenesis – developing and characterization of advanced nanoplatform for …

Principal investigator: dr hab. Monika Bzowska

Uniwersytet Jagielloński, Wydział Biochemii, Biofizyki i Bitechnologii

Call: OPUS 25, Panel: NZ6

90. 3D-printed bone implants - Exploring the relationship between the chemical and spatial structure of implants and their s…

Principal investigator: prof. Edyta Proniewicz

Akademia Górniczo-Hutnicza im. Stanisława Staszica w Krakowie, Wydział Odlewnictwa

Call: OPUS 25, Panel: ST4

91. From simple alkaloids to potentially anticancer Ir(III) and Ru(II) complexes supported by the magnetic nanoparticles.

Principal investigator: dr Daria Bogumiła Wojtala

Uniwersytet Wrocławski, Wydział Chemii

Call: PRELUDIUM 22, Panel: ST4

92. Development of novel anti-cancer immunotherapy against mesothelioma comprising of oncolytic adenovirus vectors armed wit…

Principal investigator: dr Łukasz Kuryk

Narodowy Instytut Zdrowia Publicznego - Państwowy Zakład Higieny (NIZP - PZH)

Call: SONATA 18, Panel: NZ7

93. Gaining control on XBP1s signaling as a starting point for novel cancer therapies

Principal investigator: prof. Rafał Artur Bartoszewski

Uniwersytet Wrocławski, Wydział Biotechnologii

Call: OPUS 24, Panel: NZ7

94. Molecular insights into hypoxic tumors – for development of targeted cancer therapeutics

Principal investigator: dr Marco Deiana

Politechnika Wrocławska

Call: POLONEZ BIS 3, Panel: NZ5

95. Dissecting the tumoricidal potential of ILC2s in melanoma

Principal investigator: dr Marek Wagner

Sieć Badawcza ŁUKASIEWICZ - PORT Polski Ośrodek Rozwoju Technologii

Call: SONATA BIS 12, Panel: NZ6

96. Pancreatic cancer oxygenation as a prognostic marker during anticancer therapy

Principal investigator: dr Martyna Krzykawska-Serda

Uniwersytet Jagielloński, Wydział Biochemii, Biofizyki i Biotechnologii

Call: OPUS 23, Panel: NZ5

97. Enzyme Responsive Nanoscale Supramolecular Capsules with Application in Anticancer Drug Delivery

Principal investigator: dr Venkateswarulu Mangili

Uniwersytet im. Adama Mickiewicza w Poznaniu, Centrum Zaawansowanych Technologii

Call: POLONEZ BIS 2, Panel: ST4

98. Investigation of the MLK4 biology in breast cancer and search for new therapeutic strategies using innovative PROTAC com…

Principal investigator: dr Anna Agnieszka Marusiak

Międzynarodowy Instytut Mechanizmów i Maszyn Molekularnych Polskiej Akademii Nauk

Call: SONATA BIS 11, Panel: NZ5

99. Anticancer activity of novel derivatives of 9,10-Anthraquinone Dithiocarbamates

Principal investigator: Natalia Anna Maciejewska

Politechnika Gdańska

Call: PRELUDIUM 20, Panel: NZ7

100. Improvement of therapeutic safety of parenteral nutrition in cancer patients - the interplay between supportive drugs an…

Principal investigator: Szymon Tomczak

Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

Call: PRELUDIUM 20, Panel: NZ5

Projects search